Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Advances in Chemotherapeutic Potential of Glycoconjugates against Cancer.

Created on 20 Oct 2026

Authors

Rajnish Kumar, Archna Singh, Avijit Mazumder, Salahuddin, Nardev Singh

Published in

Anti-cancer agents in medicinal chemistry. Volume 26. Issue 16. Pages 1553-1572.

Abstract

The growing interest in glycoconjugates as potential chemotherapeutic agents against cancer stems from their ability to selectively target biological processes associated with tumor growth and metastasis. Glycoconjugates- compounds in which carbohydrates are covalently linked to proteins, lipids, or other bioactive molecules-have shown considerable promise in enhancing both the efficacy and selectivity of cancer therapies. This review highlights recent advancements in the development of glycoconjugates, focusing on their roles in modulating tumor-associated glycan interactions, improving drug delivery, and overcoming resistance mechanisms. Key breakthroughs include the synthesis of novel glycoconjugate compounds that exhibit enhanced cytotoxicity toward cancer cells while minimizing effects on normal tissues. Additionally, innovative strategies utilizing glycoconjugates as drug carriers or in combination therapies have demonstrated potential in preclinical and clinical studies. These developments suggest that glycoconjugates could play a pivotal role in the future of cancer treatment, offering new avenues for targeted and personalized therapeutic approaches.

PMID:
42897893
Bibliographic data and abstract were imported from PubMed on 20 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement